Bind Biosciences appoints Dr Ed Schnipper
Published on: 06/07/10
US biopharmaceutical company Bind Biosciences has appointed Dr Ed Schnipper as chief medical officer.
Dr Schnipper joins the company with 20 years experience across the pharma and biotech sectors, most recently at Alza, where he was responsible for the clinical development of new products.
Prior to this he was senior vice president and medical director at Sequus Pharmaceuticals and before that served at Roche in various senior clinical positions.
Bind is working to develop best-in-class therapeutics based on its proprietary targeted nanotechnology platform
Dr Schnipper said: “This is a tremendous opportunity to create a new class of therapeutics through the medicinal nanoengineering of both existing and new drugs.
“From my experience in developing drugs based on liposomes, I view Bind Biosciences' targeted nanoparticle technology as an advance in developing the drugs using targeted therapeutics to increase efficacy and reduce toxicity."
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches.
InPharmjobs.com serves all industry sectors, including: clinical research jobs, pharmaceutical sales jobs, pharma marketing jobs, regulatory affairs jobs, pharmacovigilance jobs, quality assurance jobs, medical affairs jobs, senior management jobs in pharma and drug safety jobs.
